Udenafil

优地那非

Report date: 2022/08/10 14:07:55
NME

Base Information

Drug NameUdenafil
Drug Alias NameUdenafilum乌地那非udenafiloZydenaUdzire +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsHeart Failure, SystolicHeart Failure, DiastolicHeart Diseases +[11] 
Global Approved IndicationsErectile Dysfunction
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2005/01/01
Country/TerritoryCanadaUnited StatesTurkey +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesDong-A Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMezzion Pharma Co LtdDong-A Pharmaceutical Co Ltd
Inactive CompaniesDong-A Pharmtech Co LtdAbdi Ibrahim Ilac San. Ve Tic AsWarner Chilcott Ltd +[5] 
Active IndicationsHeart DiseasesErectile Dysfunction
Inactive IndicationsHeart Failure, SystolicHeart Failure, DiastolicRenal Insufficiency +[9] 

Other Information

ATC CodeG04BE11
Related LinksWikipediaDrugBankKEGG